ÕÒÂÛÎÄÍø > ҽҩѧÂÛÎÄ > ҽѧÂÛÎÄ >

ת»¯Éú³¤Òò×Ó¦Â2ÔÚ¿ÚÇ»ÁÛ°©Öеıí´ïºÍÒâÒå(2)

¡¡¡¡½üÄêÀ´TGF-¦Â2ÔÚÖ×ÁöÐγɺÍÔ¤ºóÖеÄ×÷ÓÃÒÑÖð½¥ÒýÆðÈËÃǵÄÖØÊÓ¡£MaxwellµÈ£Û7£ÝÑо¿·¢ÏÖTGF-¦Â2ÔÚÄÔ½ºÖÊÁöÖÐÓйýÁ¿±í´ï£¬¶øÔÚÕý³£×éÖ¯ÖÐÎÞ¹ýÁ¿±í´ï£¬TGF-¦Â2µÄ±í´ïÓëÄÔ½ºÖÊÁöµÄ¶ñÐԳ̶ȺÍÔ¤ºóÓйء£±¾Ñо¿·¢ÏÖTGF-¦Â2ÔÚÕý³£¿ÚÇ»ð¤Ä¤ÖÐÓÐÉÙÁ¿±í´ï£¬¿ÉÄÜÓëTGF-¦Â2¶ÔÉÏÆ¤Ï¸°ûÓÐÒÖÖÆ×÷ÓÃÓйء£ÔÚ¿ÚÇ»ÁÛ°©×éÖ¯ÖÐTGF-¦Â2±í´ïÓëÕý³£¿ÚÇ»ð¤Ä¤Ïà±È³Ê¹ý±í´ï£¬ÕâÓëÎÄÏ×±¨µ¼TGF-¦Â2ÔÚÆäËûÖ×ÁöÖеÄÑо¿½á¹ûÏàÒ»Ö£Û1¡«3£Ý¡£¿ÚÇ»ÁÛ°©TGF-¦Â2µÄ±í´ïÓë¿ÚÇ»ÁÛ°©²¡Àí·Ö¼¶¡¢ÁÙ´²·ÖÆÚ¼°ÓÐÎÞÁܰͽá×ªÒÆÃÜÇÐÏà¹Ø£¬½á¹û±íÃ÷TGF-¦Â2±í´ïԽǿ£¬¿ÚÇ»ÁÛ°©·Ö»¯Ô½²î£¬Æä¶ñÐԳ̶ÈÔ½¸ß£¬Ô½Ò×·¢Éú×ªÒÆ£¬ÌáʾTGF-¦Â2¿ÉÄܲÎÓëÁË¿ÚÇ»ÁÛ°©µÄ·¢Éú·¢Õ¹¼°¾±Áܰͽá×ªÒÆ¹ý³Ì¡£¿ÚÇ»ÁÛ°©Öеĸ÷²¿·ÖµÄÔöÖ³ÄÜÁ¦ÊDz»Í¬µÄ£¬ÔÚ¿ÚÇ»ÁÛ°©ÖÐÔöÖ³ÄÜÁ¦Ç¿µÄϸ°ûÊÇλÓÚ°©³²±ßÔµµÄÖ×Áöϸ°û£¬°©³²±ßÔµµÄÖ×Áöϸ°û±È°©³²ÖÐÐIJ¿Î»µÄÖ×Áöϸ°ûÆäÔöÖ³ÄÜÁ¦Ç¿5¡«10±¶£Û8£Ý£¬ÔöÖ³ÄÜÁ¦Ô½Ç¿£¬Ô½Ò×·¢Éú×ªÒÆ¡£±¾Ñо¿ÖÐTGF-¦Â2µÄ±í´ïλÓÚ°©³²±ßÔµµÄÖ×Áöϸ°û£¬¿ÉÄÜÓëÆä²»Í¬µÄÔöÖ³ÄÜÁ¦Óйء£ÌáʾTGF-¦Â2ÊÇÓÉÖ×Áöϸ°û·ÖÃڵģ¬TGF-¦Â2ÔÚ¿ÚÇ»ÁÛ°©ÖеĹý±í´ï¿ÉÄÜÓëÆäºÏ³É¡¢·ÖÃÚÔö¼Ó»òÊÍ·Å»úÖÆÓйء£

¡¡¡¡¶ÔTGF-¦Â2ÈçºÎµ¼ÖÂÕý³£Ï¸°û¶ñÐÔת»¯µÄ»úÀíĿǰÉв»Çå³þ¡£½üÄêÀ´Ñо¿±íÃ÷TGF-¦ÂÊÇϸ°ûÐźÅתµ¼ÏµÍ³ÖеÄÒ»²¿·Ö£¬TGF-¦ÂµÄ¹¦ÄܺÍ×÷ÓÃÊÇͨ¹ýÆä±íÃæµÄ¢ñÐÍ¡¢¢òÐÍÊÜÌå(T¦ÂR)Æð×÷Óõ쬢ñÐͺ͢òÐÍÊÜÌåÊôÓÚ¿çĤµÄË¿°±Ëá/ËÕ°±Ëἤø£¬TGF-¦ÂÓë¢ñÐÍ¡¢¢òÐÍÊÜÌå½áºÏºóÐγÉÒì¾ÛÌ帴ºÏÎï¡£TGF-¦ÂÓëÊÜÌå¼äµÄÏ໥×÷ÓöÔÍê³ÉTGF-¦ÂµÄ×÷ÓÃÊDz»¿É»òȱµÄ¡£Òò´Ë̽ÌÖTGF-¦Â2Óë¿ÚÇ»ÁÛ°©ÇÖÏ®ºÍ×ªÒÆµÄ¹ØÏµÊ±£¬ÉÐÐè´Ó¶à·½Ãæ×öÉîÈëµÄÑо¿¡£

¡¡¡¡¡¾²Î¿¼ÎÄÏס¿

¡¡¡¡1  Kim JY,Alm HJ,Zclner DJ,et al.Genetic changes in transforming growth factor ¦Â (TGF-¦Â) receptor type I genc correlates with insensivity to TGF-¦Â1 in human prostate cancer cells.Cancer Res,1996,56:46-48.

¡¡¡¡2  Eder E,Stenzl A,Hoblsch A,et al.Expression of transforming growth factor beta-l,beta-2 and beta-3 in human bladder carcinomas.Br J Cancer,1997,75(2):1753-1760.

¡¡¡¡3  Van Belle P,Rodeck U,Nuamah I,et al.Melanoma associated exprssion of transforming growth factor ¦Â isoforms.Am J Pathol,1996,148:1887-1894.

¡¡¡¡4  ¹ùÀò£¬½¯Öлª£¬³Â¹âêÊ£¬µÈ.ĤÐγɹǽáºÏµ°°×ÔÚ¹ÇȱËðÐÞ¸´µÄʵÑéÑо¿.¿Úǻҽѧ×ݺᣬ1995£¬11£º145.

¡¡¡¡5  Laiho M,Secaprio JA,Ludlow JW,et al.Growth inhibition by TGF-¦Â linked of retinoblastoma phosporylation.Cell,1990,62:175.

¡¡¡¡6  Torre-Aminone G,Deauchamp RD,Koeppen H,et al.A highly immunogenic tumor transformed with a murine transforming growth factor type ¦Â c DNA escapes immune surveillance.Proc Natl Acad Sci USA,1990,87:1486.

¡¡¡¡7  Maxwell M,Galanopoulos T,Neville-Golden J,et al.Effect of the expression of transforming growth factor-¦Â2 in primary human glioblastoma on immunosuppression and loss of immune surveillance.J Neuro Surg,1992,76(5):799-804.

¡¡¡¡8  Thomson PJ,Potten CS,Appletont DR.Charactcrization of epithelial cell activity in patients with oral cancer.Br J Oral Maxillo Sur,1999,37:384-390.

¹²2Ò³: ÉÏÒ»Ò³ [1] 2


ÖØÖ¢ÈѸßÕ÷»¼Õß²¢·¢¼±ÐÔÉöË¥µÄÔçÆÚÕï¶Ï¼°»¤Àí´ëÊ©
ÉçÇø½¡¿µ´Ù½øÊµ¼ùÌå»á
¹¤É̹ÜÀí | ¹¤¿ÆÂÛÎÄ | ²ÆÎñ¹ÜÀí | ¹ÜÀíѧ | ¹«¹²¹ÜÀí | ²ÆÕþ˰ÊÕ | ֤ȯ½ðÈÚ | »á¼ÆÉó¼Æ | ¼ÆËã»ú | ·¨ÂÉÂÛÎÄ | ҽҩѧ | ººÓïÑÔÎÄѧ
Éç»áÂÛÎÄ | ¹¤¿ÆÂÛÎÄ | Àí¿ÆÂÛÎÄ | ÎÄ»¯ÂÛÎÄ | ÒÕÊõÂÛÎÄ | ÎÄѧÂÛÎÄ | ÕÜѧÂÛÎÄ | ÕþÖÎÂÛÎÄ | Ó¢ÓïÂÛÎÄ | д×÷Ö¸µ¼ | ¼ÆËã»úÓ¦ÓÃ
www.zlunwen.com ÕÒÂÛÎÄÍø ® °æÈ¨ËùÓÐ ÍøÕ¾µØÍ¼